The biotech startup Inscripta is attempting to “democratize” CRISPR by offering it to select researchers at no cost, according to Fortune. Here are four things to know about the startup’s business ...

Charles Gersbach and his colleagues are pursuing promising CRISPR technologies focused on controlling gene activity rather ...

There are plenty of reasons, though, to be bullish on the stock, not the least of which is its improved cash position. The ...

A platform approach to gene editing brings together design, manufacturing, validation, analytics, and regulatory considerations right from the start.

Oct 7, 2020, 9:38am CDT Updated: Oct 7, 2020, 10:06am CDT Spencer A. Brown FILE — CRISPR gene-editing technology inventor Jennifer Doudna of the University of California, Berkeley, accepts the Life ...

Last year’s federal agency layoffs, grant discontinuations, and university funding cuts led to numerous warnings of the disastrous impact on U.S. science research. Gretchen Goldman, PhD, from the ...

The benefits of CAR-T therapies, which have been used to treat 27,000 patients, outweigh the risks that these therapies pose to patients, Peter Marks, director of US Food and Drug Administration (FDA) ...